A Year After IPO, Entelos Targets Drug Repositioning, Oncology PhysioLab in '07

Other goals include expanding the company’s customer base into consumer healthcare, and a growth strategy that includes acquiring companies with technology platforms “complementary” to its own predictive methodology.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.